Literature DB >> 2126833

Effect of volatile anesthetics on endogenous tryptophan, 5-hydroxytryptophan and 5-hydroxytryptamine in rat lung.

A Parent-Ermini1, R R Ben-Harari.   

Abstract

Volatile anesthetics inhibit the pulmonary inactivation of 5-hydroxytryptamine (5-HT) possibly via an effect on endogenous lung 5-HT. The consequent higher systemic arterial 5-HT concentrations may predispose the heart to dysrhythmias. The direct effect of the anesthetics on endogenous 5-HT, its metabolites, and precursors in the isolated ventilated perfused rat lung was determined by high-pressure liquid chromatography. Halothane (0.45, 1.4, and 2.3 minimum alveolar concentration (MAC] and 35% nitrous oxide (N2O) increased lung 5-HT (11, 70, 94, and 54% respectively). The effect of 0.45 MAC halothane and 35% N2O on 5-HT was synergistic. Isoflurane (2.9 MAC) had no effect on lung 5-HT. The lung concentration of tryptophan (TRP) was increased 51% by 2.9 MAC isoflurane, but the rate of efflux of TRP from the lung was unchanged. There was no effect of the anesthetics on 5-hydroxytryptophan (5-HTP). The ratio of 5-HT:5-HTP was significantly increased by 2.3 MAC halothane and 0.5 MAC halothane +35% N2O. The 5-HTP:TRP ratio was unchanged. The metabolite of 5-HT, 5-hydroxyindole acetic acid (5-HIAA), was not always detected. The results suggest that the increase in lung 5-HT by halothane reflects an increase in 5-HTP decarboxylase activity and that halothane and isoflurane exert selective effects on lung 5-HT synthesis. The results do not support the hypothesis that lung 5-HT controls the inactivation of 5-HT in the pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126833     DOI: 10.1007/bf02719702

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  26 in total

1.  THE UPTAKE OF BIOGENIC AMINES BY MAST CELLS OF THE RAT.

Authors:  A V FURANO; J P GREEN
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  Additive effects of anesthetics and theories of anesthesia.

Authors:  C A DiFazio; R E Brown; C G Ball; C G Heckel; S S Kennedy
Journal:  Anesthesiology       Date:  1972-01       Impact factor: 7.892

3.  Effects of pulmonary irritants on DNA, ATPase activity, and histamine on rat lung.

Authors:  S R Cronin; S N Giri
Journal:  Proc Soc Exp Biol Med       Date:  1974-05

4.  Effects of halothane and nitrous oxide on removal of norepinephrine from the pulmonary circulation.

Authors:  H Naito; C N Gillis
Journal:  Anesthesiology       Date:  1973-12       Impact factor: 7.892

5.  Cerebrovascular endothelial cell culture: metabolism and synthesis of 5-hydroxytryptamine.

Authors:  C Maruki; M Spatz; Y Ueki; I Nagatsu; J Bembry
Journal:  J Neurochem       Date:  1984-08       Impact factor: 5.372

6.  Mechanisms influencing the disposition of serotonin in mouse lung.

Authors:  T R Bosin; P D Lahr
Journal:  Biochem Pharmacol       Date:  1981-12-01       Impact factor: 5.858

7.  Pulmonary synthesis of 5-hydroxytryptamine in isolated perfused rabbit and rat lung preparations.

Authors:  K Gonmori; K S Rao; H M Mehendale
Journal:  Exp Lung Res       Date:  1986       Impact factor: 2.459

8.  Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine.

Authors:  C Sadavongvivad
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

9.  Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation.

Authors:  D R Cook; B W Brandom
Journal:  Anesth Analg       Date:  1982-08       Impact factor: 5.108

Review 10.  Isoflurane: an anesthetic for the eighties?

Authors:  J G Wade; W C Stevens
Journal:  Anesth Analg       Date:  1981-09       Impact factor: 5.108

View more
  1 in total

1.  Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

Authors:  Neide M Silva; Cibele V Rodrigues; Marcelo M Santoro; Luiz F L Reis; Jacqueline I Alvarez-Leite; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.